Syra Health Corp
No SEC Form 4 filings for $SYRA in the last 30 days.
See all $SYRA insider activity →Syra Health Corp. (OTCQB: SYRA) secured a three-year, $240,000 contract with the Mississippi State Department of Health for public health analytics services, with options for two one-year renewals. The company will provide statistical analyses, population health assessments, and GIS mapping of health data to support public health decision-making.
Syra Health (SYRA) and HealthSync joined the CMS ACCESS model to expand behavioral health access for Medicare beneficiaries. Syrenity, Syra's digital platform, showed efficacy in reducing depression and anxiety. CEO Alexander sees potential for long-term revenue. SYRA stock is currently at $0.93, ranging $0.05-$1.15 in the past year.
Syra Health (SYRA) and HealthSync were accepted into the CMS ACCESS model, a federal program focused on chronic and behavioral healthcare for Medicare beneficiaries. The partnership aims to use Syra Health's Syrenity platform, which has shown clinical benefits, but the agreement is not yet final. The CEO sees potential for long-term revenue, though no financial projections were provided.
Over the past 7 days, AlphAI's AI scored 1 news story mentioning SYRA (Syra Health Corp). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.
Recent SYRA coverage spans financial news, regulation and earnings.
The contract win provides modest revenue visibility and may lift sentiment for the micro‑cap.
Potential revenue uplift from Medicare reimbursements for behavioral health referrals.
Syra Health (SYRA) and HealthSync were accepted into the CMS ACCESS model, a federal program focused on chronic and behavioral healthcare for Medicare beneficiaries. The partnership aims to use Syra Health's Syrenity platform, which has shown clinical benefits, but the agreement is not yet final. The CEO sees potential for long-term revenue, though no financial projections were provided.
Profitability returned and margins expanded, supported by revenue growth and operating leverage, plus multiple contract extensions.
The filing is a routine corporate governance update with no new financial guidance, deal, or regulatory action.
AlphAI scores every news story that mentions SYRA with an AI model for sentiment and relevance, and aggregates insider trades from Syra Health Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.
Syra Health Corp. (OTCQB: SYRA) secured a three-year, $240,000 contract with the Mississippi State Department of Health for public health analytics services, with options for two one-year renewals. The company will provide statistical analyses, population health assessments, and GIS mapping of health data to support public health decision-making.
1 min readSyra Health (SYRA) and HealthSync joined the CMS ACCESS model to expand behavioral health access for Medicare beneficiaries. Syrenity, Syra's digital platform, showed efficacy in reducing depression and anxiety. CEO Alexander sees potential for long-term revenue. SYRA stock is currently at $0.93, ranging $0.05-$1.15 in the past year.
2 min readSyra Health (SYRA) and HealthSync were accepted into the CMS ACCESS model, a federal program focused on chronic and behavioral healthcare for Medicare beneficiaries. The partnership aims to use Syra Health's Syrenity platform, which has shown clinical benefits, but the agreement is not yet final. The CEO sees potential for long-term revenue, though no financial projections were provided.
2 min readSyra Health Corp (SYRA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Syra Health Achieves 23% Revenue Growth, Improves Gross Margin to 44.5% in Second Consecutive Profitable Quarter ● Syra Health sustained profitability in Q2 2026, following the Company’s first profitable quarter in Q1 2026, delivering net income of $250,242 compared
6 min readSyra Health Corp (SYRA) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. false 0001922335 0001922335 2026-07-23 2026-07-23 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Repor
2 min readSyra Health Corp. (OTCQB: SYRA) appointed Dr. Cori McMahon, PsyD, NCCE, as Chief Medical Officer on a fractional basis. The company said the role will strengthen engagement with healthcare stakeholders and support expansion of its behavioral health and population health solutions across commercial and public sectors.
2 min readCARMEL, Ind., July 17, 2025 /PRNewswire/ -- Syra Health SYRA, a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today it has been awarded a new contract with a major insurance provider to staff registered nurses to ...
2 min readCARMEL, Ind., May 27, 2025 /PRNewswire/ -- Syra Health Corp.
2 min read
